Medical Pharmacology Chapter 36: Antiviral Drugs
Antiviral Drugs
Anti-viral drugs with activity against HIV (Human Immunodeficiency Virus)
Introduction: Human Retroviruses continued
In 1983 HIV (human immunodeficiency virus) was isolated from a patient exhibiting lymphadenopathy.2
The following year HIV was identified as the causative agent in acquired immunodeficiency syndrome (AIDS).
The year after that, in 1985, a sensitive test was developed for HIV: the enzyme-linked immunosorbent assay (ELISA).
The availability of this test allowed a more comprehensive assessment of the HIV epidemic both in the United States and eventually worldwide.2
The evolution of the HIV pandemic occurred concurrently with rapid expansion of understanding HIV biology.2
Areas of interest include:
HIV virology
Pathogenesis
HIV disease treatment
Prophylaxis and treatment of AIDS infection-induced opportunistic disease
Infection prevention as well as
Efforts to develop a vaccine2
The retroviruses (family: Retroviridae) exhibit tropism mainly for vertebrates.3
As suggested earlier, the term retrovirus indicates that information initially in the form of RNA undergoes in the host cell transcription into DNA.3
This observation ran counter to the established molecular biology dogma that information moved in a unidirectional way from DNA→ RNA → protein.
The family Retroviridae is composed of seven subfamilies.
Genus |
Example | Characteristic |
Alpharetrovirus |
Rous Sarcoma Virus |
Presence of src oncogene |
Betaretrovirus |
Mouse Mammary Tumor Virus |
May be Exogenous or Endogenous |
Gammaretrovirus |
Abelson Mouse Leukemia Virus |
Presence of abl oncogene |
Deltaretrovirus |
HTLV-I |
Causative in T Cell Lymphoma and some Neurologic Disorders |
Epsilonretrovius |
Walleye Dermal Sarcoma Virus |
-- |
Lentivirus |
HIV-1,2 |
Causative for AIDS |
Spumavirus |
Simian Foamy Virus |
Non-pathogenic in Humans |
Members of two of the families infects humans and cause pathologies.3
The deltaretroviruses, include human T-cell lymphotropic virus (HTLV) type I which is the most important one for humans.
The lentiviruses of which human immunodeficiency virus (HIV) is the most important one in humans.3
Retroviruses are spherical with the envelope containing external surface protein (SU) which is associated with transmembrane protein (TM) extending across the lipid bilayer.5
The inner surface of the membrane is coded with viral matrix protein.
Capsid protein, CA, depending on the virus strain, describes an icosahedral or conical core.
Capsid structures are described as having icosahedral or helical symmetry.
The surface of an icosahedron is described by 60 identical subunits.10
Accordingly, 60 structural units are required to create the viral shell that encapsulates its genome.
Despite the virus expressing icosahedral symmetry, viral shape in terms of physical appearance is spherical.10
Icosahedral structures, although resembling spheres, exhibit 2-fold, 3-and 5-fold symmetry axes.
|
|
|
The virus core is associated with three important viral-encoded enzymes.
These are:
Reverse transcriptase (RT)
Protease (PR) and
Integrase (IN).5
Viral structural proteins are designated on the basis of both their glycosylation characteristics and molecular weights.5
For HIV:
External surface protein, SU is called gp120
Transmembrane protein, TM, is gp41 and
Capsid protein is p24.5
The virus genome is a positive-strand RNA along with the nucleocapsid protein (NC).5
Genomic RNAs are capped at the 5' terminal and polyadenylated at the 3' terminal.
Viral proteins are derived from three genes:
gag ("group-specific antigen)
pol (polymerase) and
env (envelope protein).5
gag codes for a polyprotein which is later processed, thus releasing major viral structural proteins.1
pol overlaps gag and encodes for three enzyme proteins:1
(a) One with an RNA-dependent DNA polymerase or reverse transcriptase with RNAase activity.
(b) A second with protease activity.
(c) A third with viral integrase activity.1
env encodes for the large transmembrane envelope protein that mediates viral-cell binding and viral entry.1
Additional small genes are involved in encoding regulatory proteins which promote virion production or inhibit host defenses.
These genes include:1,6
tat (transactivator of transcription)
rev (Regulator of expression of virion proteins)
nef (Negative effector)
vpr (Virion protein R [structural protein])
|
|
This Web-based pharmacology and disease-based integrated teaching site is based on reference materials, that are believed reliable and consistent with standards accepted at the time of development. Possibility of human error and on-going research and development in medical sciences do not allow assurance that the information contained herein is in every respect accurate or complete. Users should confirm the information contained herein with other sources. This site should only be considered as a teaching aid for undergraduate and graduate biomedical education and is intended only as a teaching site. Information contained here should not be used for patient management and should not be used as a substitute for consultation with practicing medical professionals. Users of this website should check the product information sheet included in the package of any drug they plan to administer to be certain that the information contained in this site is accurate and that changes have not been made in the recommended dose or in the contraindications for administration. Advertisements that appear on this site are not reviewed for content accuracy and it is the responsibility of users of this website to make individual assessments concerning this information. Medical or other information thus obtained should not be used as a substitute for consultation with practicing medical or scientific or other professionals. |